Jessica M. Pastoriza

General Surgery

4306 Alton Rd Fl 2
Miami Beach, FL 33140

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

ASO Visual Abstract: Zip-Code-Level Disadvantage as a Predictor of Metastatic Breast Cancer at Diagnosis and Delayed Treatment Initiation.

ASO Visual Abstract: Zip-Code-Level Disadvantage as a Predictor of Metastatic Breast Cancer at Diagnosis and Delayed Treatment Initiation.

Journal: Annals of surgical oncology

Published: January 04, 2026

Refining Sentinel Lymph Node Biopsy Decisions for Clinically Node-Negative Microinvasive DCIS.

Refining Sentinel Lymph Node Biopsy Decisions for Clinically Node-Negative Microinvasive DCIS.

Journal: The breast journal

Published: September 23, 2025

Zip-Code Level Disadvantage as a Predictor of Metastatic Breast Cancer at Diagnosis and Delayed Treatment Initiation.

Zip-Code Level Disadvantage as a Predictor of Metastatic Breast Cancer at Diagnosis and Delayed Treatment Initiation.

Journal: Annals of surgical oncology

Published: April 29, 2025

Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study.

Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: November 07, 2024

Case report: IORT as an alternative treatment option for breast cancer patients with difficulty staying still.

Case report: IORT as an alternative treatment option for breast cancer patients with difficulty staying still.

Journal: Frontiers in oncology

Published: May 07, 2024

Comprehensive strategies in breast cancer-related lymphedema prevention: insights from a multifaceted program.

Comprehensive strategies in breast cancer-related lymphedema prevention: insights from a multifaceted program.

Journal: Frontiers in oncology

Published: April 16, 2024

Axillary Reverse Mapping Aids in Reducing the Rates of Breast Cancer-Related Lymphedema in Underserved Ethnically Diverse Population.

Axillary Reverse Mapping Aids in Reducing the Rates of Breast Cancer-Related Lymphedema in Underserved Ethnically Diverse Population.

Journal: Annals of surgical oncology

Published: April 01, 2024

Can the Clinical Utility of iBreastExam, a Novel Device, Aid in Optimizing Breast Cancer Diagnosis? A Systematic Review.

Can the Clinical Utility of iBreastExam, a Novel Device, Aid in Optimizing Breast Cancer Diagnosis? A Systematic Review.

Journal: JCO global oncology

Published: December 12, 2023

Mucoepidermoid carcinoma-a rare salivary gland-type tumor of the breast: are we dealing with primary or secondary?-a case report and literature review.

Mucoepidermoid carcinoma-a rare salivary gland-type tumor of the breast: are we dealing with primary or secondary?-a case report and literature review.

Journal: Gland surgery

Published: September 06, 2023

Case Report: Bilateral targeted intraoperative radiotherapy: a safe and effective alternative for synchronous bilateral breast cancer.

Case Report: Bilateral targeted intraoperative radiotherapy: a safe and effective alternative for synchronous bilateral breast cancer.

Journal: Frontiers in oncology

Published: August 13, 2023

Does Nipple-Ward Positive Margin Contribute to a Higher Rate of Re-Excision Procedures After a Lumpectomy with Pathology-Confirmed Positive Margins? A Retrospective Study.

Does Nipple-Ward Positive Margin Contribute to a Higher Rate of Re-Excision Procedures After a Lumpectomy with Pathology-Confirmed Positive Margins? A Retrospective Study.

Journal: Breast cancer (Dove Medical Press)

Published: June 14, 2023

Racial disparity in tumor microenvironment and distant recurrence in residual breast cancer after neoadjuvant chemotherapy.

Racial disparity in tumor microenvironment and distant recurrence in residual breast cancer after neoadjuvant chemotherapy.

Journal: NPJ breast cancer

Published: December 16, 2022

Showing 1-12 of 23

Last Updated: 09/26/2026